Stock-Based and Deferred Compensation Plans (Tables)

12 Months Ended

Dec. 31, 2021

The following table summarizes stock options and stock appreciation rights activity:

	Successor				Predecessor
	September 8, 2021 to December 31, 2021				January 1, 2021 to September 7, 2021					Year Ended December 31, 2020					Year Ended December 31, 2019
(in thousands, except per share amounts)	Shares		Weighted- Average Exercise Price Per Share		Shares			Weighted- Average Exercise Price Per Share		Shares			Weighted- Average Exercise Price Per Share		Shares			Weighted- Average Exercise Price Per Share
Outstanding at beginning of period		—	$	—		143		$	18.37		144		$	18.35		151		$	18.29
Exercised		—		—		—			—		—			—		—			—
Forfeited		—		—		—			—		(1	)		17.05		(7	)		17.05
Awards cancelled pursuant to Merger Agreement		—		—		(143	)		18.37		—			—		—			—
Outstanding and exercisable at end of period		—	$	—		—		$	—		143		$	18.37		144		$	18.35
(dollars in millions)
Compensation expense for the period	$	—			$	—				$	—				$	—
Tax benefit related to compensation expense	$	—			$	—				$	—				$	—
Intrinsic value of awards exercised	$	—			$	—				$	—				$	—
Cash received from awards exercised	$	—			$	—				$	—				$	—
Grant date fair value of awards vested	$	—			$	—				$	—				$	—

The following table summarizes our outstanding performance-based restricted award activity:

	Successor				Predecessor
	September 8, 2021 to December 31, 2021				January 1, 2021 to September 7, 2021					Year Ended December 31, 2020					Year Ended December 31, 2019
(in thousands, except per share amounts)	Shares		Weighted- Average Exercise Price Per Share		Shares			Weighted- Average Exercise Price Per Share		Shares			Weighted- Average Exercise Price Per Share		Shares			Weighted- Average Exercise Price Per Share
Non-vested at beginning of period		—	$	—		1,037		$	10.87		1,282		$	13.00		692		$	18.67
Granted*		—		—		—			—		—			—		763			8.34
Vested		—		—		(1,037	)		10.87		(245	)		22.03		(160	)		15.45
Forfeited		—		—		—			—		—			—		(13	)		11.32
Non-vested at end of period		—	$	—		—		$	—		1,037		$	10.87		1,282		$	13.00
(dollars in millions)
Compensation expense for the period	$	—			$	6.2				$	2.4				$	2.7
Tax benefit related to compensation expense	$	—			$	(1.5	)			$	(0.5	)			$	(0.6	)
Grant date fair value of awards vested	$	—			$	11.3				$	5.4				$	2.5

*	Assumes the maximum number of awards that can be earned if the performance conditions are achieved.

The following table summarizes our time-based restricted award activity:

	Successor				Predecessor
	September 8, 2021 to December 31, 2021				January 1, 2021 to September 7, 2021					Year Ended December 31, 2020					Year Ended December 31, 2019
(in thousands, except per share amounts)	Shares		Weighted- Average Exercise Price Per Share		Shares			Weighted- Average Exercise Price Per Share		Shares			Weighted- Average Exercise Price Per Share		Shares			Weighted- Average Exercise Price Per Share
Non-vested at beginning of period		—	$	—		792		$	11.42		942		$	11.67		497		$	17.02
Granted		—		—		—			—		68			14.99		625			8.43
Vested		—		—		(792	)		11.42		(216	)		13.58		(167	)		15.39
Forfeited		—		—		—			—		(2	)		15.70		(13	)		12.76
Non-vested at end of period		—	$	—		—		$	—		792		$	11.42		942		$	11.67
(dollars in millions)
Compensation expense for the period	$	—			$	6.9				$	3.2				$	4.7
Tax benefit related to compensation expense	$	—			$	(1.7	)			$	(0.7	)			$	(1.1	)
Grant date fair value of awards vested	$	—			$	9.0				$	2.9				$	2.6